tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Martin Auster, 141 are a BUY (72.31%), 9 are a SELL (4.62%), 45 are a HOLD (23.08%).
Analyst Martin Auster, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 59.85% that have a potential upside of 23.86% achieved within 227 days. Previously, Martin Auster worked at CREDIT SUISSE, UBS.
Martin Auster’s has documented 386 price targets and ratings displayed on 41 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on BBIO, BridgeBio Pharma at 26-May-2026.
Analyst best performing recommendations are on ALNY (ALNYLAM PHARMACEUTICALS).
The best stock recommendation documented was for ALNY (ALNYLAM PHARMACEUTICALS) at 7/29/2025. The price target of $370 was fulfilled within 2 days with a profit of $39.45 (11.93%) receiving and performance score of 59.67.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 2 months 3 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 2 months 5 days ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 2 months 12 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 5 months 4 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 5 months 4 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
Which stock is Martin Auster is most bullish on?
Which stock is Martin Auster is most reserved on?
What Year was the first public recommendation made by Martin Auster?
